XVIVO - Impressive organic growth
2023-07-14 07:45:00
Redeye updates our outlook after Q2. XVIVO’s result indicated a mix of organisational improvements and strong demand. Again XVIVO beat both our and market expectations. We make a minor positive sales revision driven by a positive Disposable and Services revision together a slightly higher OPEX level reflecting investments in ongoing and approaching launches. We increase our base case to SEK 415 (405) with a Bull of SEK 800 and a Bear of SEK 105.
Read more and download the Research Update.
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/